Additional Metadata
Persistent URL dx.doi.org/10.1007/s00259-018-4184-z, hdl.handle.net/1765/115753
Journal European Journal of Nuclear Medicine and Molecular Imaging
Citation
Verburg, F.A, Giovanella, L., Iakovou, I, Konijnenberg, M, Langsteger, W., Lassmann, M, … Luster, M. (2018). I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?. European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2247–2249. doi:10.1007/s00259-018-4184-z